Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 1, 1997, Pages 8-15

  Pieper, Galen M ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Endothelium; Nitric oxide; Nitric oxide synthase; Tetrahydrobioptern

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE SYNTHASE; STREPTOZOCIN; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROGLYCERIN; PTERINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031033321     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199701000-00002     Document Type: Article

References (40)

1. Mülsch A, Busse R. Nitric oxide synthase in native and cultured endothelial cells: calcium/calmodulin and tetrahydrobiopterin are co-factors. J Cardiovasc Pharmacol 1991;17(suppl 3):S52-6.
2. Schmidt K, Werner ER, Mayer B, Wachter H, Kukovetz WR. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem J 1992;281:297-300.
3. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992;281:627-30.
4. Hamon CG, Culter P, Blair JA. Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats. Clin Chim Acta 1989;181:249-54.
5. Pieper GM. Oxidative stress in diabetic blood vessels. FASEB J 1995;9:A891.
6. Patil PN, Fudge K, Jacobowitz D. Steric aspects of adrenergic drugs. VIII. Alpha adrenergic receptors of mammalian aorta. Eur J Pharmacol 1972;19:79-87.
7. Hart JL, Freas W, McKenzie JE, Muldoon SM. Adrenergic nerve function and contractile activity of the caudal artery of the streptozotocin diabetic rat. J Auton Nerv Syst 1988;25:49-57.
8. Cohen RA, Tesfamariam B, Weisbrod RM, Zitnay KM. Adrenergic denervation in rabbits with diabetes mellitus. Am J Physiol 1990;259:H55-61.
9. Pieper GM, Gross GJ. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1988;255: H825-33.
10. Kamata K, Miyata N, Kasuya Y. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 1989;249:890-4.
11. Pieper GM, Peltier BA. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic in diabetic endothelium. J Cardiovasc Pharmacol 1995;25:397-403.
12. Pieper GM, Jordan M, Adams MB, Roza AM. Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes. Diabetes 1995;44:1106-13.
13. Mayer B, Klatt P, Werner ER, Schmidt K. Kinetics of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 1995;270:655-9.
14. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986;131:75-8.
15. Kamata K, Miyata N, Kasuya Y. Impairment of endothelium-dependent relaxation and changes on levels of cyclic GMP in aorta from streptozocin-induced diabetic rats. Br J Pharmacol 1989;97:614-8.
16. 2. Am J Physiol 1989;257: H1327-33.
17. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 1991;260:H319-26.
18. Diederich D, Skopec J, Diederich A, Dai FX. Endothelial dysfunction in mesenteric resistance arteries of diabetic rat: role of free radicals. Am J Physiol 1994;266:H1153-61.
19. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dcpendent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88: 2510-6.
20. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:771-6.
21. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 1992;263:H257-65.
22. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol 1992;263:H676-80.
23. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992;263: H321-6.
24. Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci 1996;58:PL147-52.
25. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992;35:1011-9.
26. Chang KSK, Stevens WC. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 1992;107:983-90.
27. 2+, on basal and agonist-stimulated nitric oxide activity. Biochem Biophys Res Commun 1996;219:584-90.
28. Schaffner A, Blau N, Schneemann M, Steurer J, Edgell C-JS, Schoedon G. Tetrahydrobiopterin as another EDRF in man. Biochem Biophys Res Commun 1994;205:516-23.
29. Nunokawa Y, Ishihara T, Kanai T, Noguchi T. (6R)-5,6,7,8-Tetradhyro-L-biopterin modulates nitric oxide-associated soluble guanylate cyclase activity in the rat cerebellum. Arch Biochem Biophys 1992;298:726-30.
30. Schmidt HHH, Pollock JS, Nakane M, Gorsky LD, Förstermann U, Murad F. Purification of a soluble isoform of guanylyl cyclase-activating factor synthase. Proc Natl Acad Sci USA 1991;88: 365-9.
31. Abou-Donia MM, Duch DS, Nichol CA, Viveros OH. Hormonal regulation of guanosine triphosphate cyclohydrolase activity and biopterin levels in the rat adrenal cortex. Endocrinology 1983; 112:2088-94.
32. Mayer B, Werner WR. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn-Schmiedebergs Arch Pharmacol 1995;351:453-63.
33. Giovanelli J, Campos KL, Kaufman S. Tetrahydrobiopterin, a co-factor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci USA 1991;88:7091-5.
34. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. Macrophage nitric oxide synthase subunits: purification, characterization and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem 1993;268:21120-9.
35. Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER, Mayer B. The pteridine binding site of brain nitric oxide synthase-tetrahydrobiopterin binding kinetics, specificity and allosteric interaction with the substrate domain. J Biol Chem 1994;269:13861-6.
36. Klatt P, Schmidt K, Brunner F, Mayer B. Inhibitors of brain nitric oxide synthase: binding kinetics, metabolism and enzyme inactivation. J Biol Chem 1994;269:1674-80.
37. Brand MP, Heales SJR, Land JM, Clark JB. Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hphl mouse. J Inher Metab Dis 1995;18:33-9.
38. Hyun J, Komori Y, Chaudhuri G, Ignarro LJ, Fukuto JM. The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase. Biochem Biophys Res Commun 1995;206:380-6.
39. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 1995;91:139-44.
40. Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM. Peroxidative stress in diabetic blood vessels: reversal by pancreatic islet transplantation. Diabetes 1995;44:884-9.